BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17039981)

  • 1. Predictors of death within six months in patients with advanced AIDS.
    Brechtl JR; Patrick PA; Visintainer P; Brand DA
    Palliat Support Care; 2005 Dec; 3(4):265-72. PubMed ID: 17039981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV as a chronic disease: implications for long-term care at an AIDS-dedicated skilled nursing facility.
    Selwyn PA; Goulet JL; Molde S; Constantino J; Fennie KP; Wetherill P; Gaughan DM; Brett-Smith H; Kennedy C
    J Urban Health; 2000 Jun; 77(2):187-203. PubMed ID: 10856000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes.
    Brechtl JR; Breitbart W; Galietta M; Krivo S; Rosenfeld B
    J Pain Symptom Manage; 2001 Jan; 21(1):41-51. PubMed ID: 11223313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for the survival of patients with AIDS cholangiopathy.
    Ko WF; Cello JP; Rogers SJ; Lecours A
    Am J Gastroenterol; 2003 Oct; 98(10):2176-81. PubMed ID: 14572564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy and declining AIDS mortality in New York City.
    Messeri P; Lee G; Abramson DM; Aidala A; Chiasson MA; Jessop DJ
    Med Care; 2003 Apr; 41(4):512-21. PubMed ID: 12665715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
    Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
    Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer.
    Cheng L; DeJesus AY; Rodriguez MA
    J Pain Symptom Manage; 2017 Apr; 53(4):720-727. PubMed ID: 28062337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.
    Sackoff JE; Hanna DB; Pfeiffer MR; Torian LV
    Ann Intern Med; 2006 Sep; 145(6):397-406. PubMed ID: 16983127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy].
    Reus S; Portilla J; Gimeno A; Sánchez-Payá J; García-Henarejos JA; Martínez-Madrid O; Usó J; Roca B; Galindo MJ; López-Aldeguer J
    Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):142-9. PubMed ID: 14987534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective cohort study on survival status of AIDS patients among 15 or above-year-olds in Henan province, from 2008 to 2015].
    Yang WJ; Li N; Liang Y; Li J; Fan PY; Sun DY; Zhu Q; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):173-178. PubMed ID: 28231661
    [No Abstract]   [Full Text] [Related]  

  • 14. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
    Chan KC; Wong KH; Lee SS
    HIV Med; 2006 Apr; 7(3):186-92. PubMed ID: 16494633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: a 5-year prospective study.
    Hsu SF; Yang SP; Chan YJ; Wang YW
    J Microbiol Immunol Infect; 2011 Jun; 44(3):198-203. PubMed ID: 21524614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A retrospective cohort study on reduction of AIDS mortality among patients enrolled in national-free antiretroviral treatment programme in two cities in China].
    Dou ZH; Zhao Y; He Y; He WS; Ji GP; Xu C; Ma Y; Zhao DC; Yu L; Zhang FJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Dec; 43(12):1091-5. PubMed ID: 20193506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective cohort study on the mortality of AIDS patients in Guangxi, China (2001-2011).
    Li M; Zhu Q; Zheng W; Pan P; Liang H; Ye L; Wang X; Zhu J; Li G; Dong B
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):439-47. PubMed ID: 25420616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.
    Arici C; Ripamonti D; Ravasio V; Maggiolo F; Rizzi M; Finazzi MG; Suter F
    Int J STD AIDS; 2001 Sep; 12(9):573-81. PubMed ID: 11516366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of HAART in Brazil, 1998-2008: a nationwide assessment of survival times after AIDS diagnosis among men who have sex with men.
    Malta M; da Silva CM; Magnanini MM; Wirtz AL; Perissé AR; Beyrer C; Strathdee SA; Bastos FI
    BMC Public Health; 2015 Mar; 15():226. PubMed ID: 25886530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.
    Schneider MF; Gange SJ; Williams CM; Anastos K; Greenblatt RM; Kingsley L; Detels R; Muñoz A
    AIDS; 2005 Nov; 19(17):2009-18. PubMed ID: 16260908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.